Your session is about to expire
← Back to Search
fb-PMT for Glioblastoma
Study Summary
This trial is studying a new cancer drug to see if it is effective in treating brain tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on a stable or decreasing dose of steroids.I haven't had a stroke, heart attack, severe heart issues, or major blood vessel problems in the last 6 months.My brain cancer has returned for the first or second time.I haven't had major blood vessel problems like aneurysms or clots in the last 6 months.My high blood pressure is under control with stable medication.I have been cancer-free and off treatment for any other cancer than non-melanoma skin cancer or cervical carcinoma in-situ for at least 3 months.I do not have any serious infections or illnesses right now.I have a serious or non-healing wound, ulcer, or bone fracture.I am mostly able to care for myself but may not be able to do active work.I can store medicine in a fridge, give daily shots, and keep a treatment diary.I haven't had any major abdominal issues like a fistula, perforation, or abscess in the last 6 months.My cancer has worsened after specific targeted radiation treatments.I am not taking any medications that affect my heart's rhythm.I have completed and recovered from standard treatments for glioblastoma, including surgery and radiotherapy.I agree to use contraception and not donate sperm during and for 2 months after the study.My recent tests show my organs and bone marrow are working well.I haven't used bevacizumab or any experimental drugs in the last 28 days.I have a history of or risk factors for a specific heart rhythm problem.I haven't taken drugs that affect liver transport proteins in the last 14 days or longer.I have previously been treated with fb-PMT or similar drugs.I have a condition that increases my risk of blood clots.I had surgery within the last 28 days and the wound has not fully healed.I haven't had major heart problems like heart failure or a heart attack in the last 6 months.My heart condition is not severe.I do not have a bleeding disorder or a history of bleeding problems in the last 28 days.
- Group 1: Treatment (fb-PMT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Food and Drug Administration sanctioned fb-PMT for medicinal use?
"Our team at Power assigned fb-PMT a score of 1 as its safety and efficacy has only been tested in limited capacities, thus making it a Phase 1 trial."
Are there any open enrolments for this experiment?
"Affirmative. The records hosted on clinicaltrials.gov verify that this medical study, initially posted on June 23rd 2022, is in search of recruits. 28 individuals need to be recruited from one particular trial centre."
How many individuals are eligible to participate in this experiment?
"Affirmative, the study is recruiting for 28 participants across a single site. Clinicaltrials.gov documents that this trial was initially posted on June 23rd 2022 and most recently revised on August 17th 2022."
Share this study with friends
Copy Link
Messenger